Buy & Sell ADMA Biologics Inc (ADMA) – ADMA Biologics Inc Price Today
Aura AI Summary
Key Stats
- $2.21BMarket Cap
- HealthSector
- -54.65%3M Drawdown
- $2.20BEnterprise Value
- -Dividend Yield
- 49% Buy | 51% SellTrading Activity
- 5 daysTypical Hold Time
ADMA Biologics Inc (ADMA) is currently valued at a market capitalization of $2.21B, with an enterprise value of $2.20B. Over the past 52 weeks, ADMA Biologics Inc has traded between a low of $8.29 and a high of $24.51, highlighting its annual price range. Over the past three months, ADMA Biologics Inc has recorded a drawdown of -54.65%, reflecting recent price volatility. ADMA Biologics Inc offers a dividend yield of -. On average, investors hold ADMA Biologics Inc for approximately 5 days, indicating typical investor behavior on the platform.
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.










